Filgrastim biosimilar (Emcure Pharmaceuticals)

非格司亭生物类似药（Emcure Pharmaceuticals）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Emcure Pharmaceuticals)

Drug Alias NamerhG-CSF (Emcure Pharmaceuticals)重组人粒细胞刺激因子（Emcure Pharmaceuticals）Recombinant filgrastim biosimilar (Emcure Pharmaceuticals)非格司亭生物仿制药（Emcure Pharmaceuticals）Recombinant human granulocyte macrophage colony stimulating factor (Emcure Pharmaceuticals) +[6]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2013/01/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesEmcure Pharma

China Registration ClassN/A

Develop Information

Active CompaniesEmcure Pharma

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02